Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response

Virus Genotype ◽

Genotype 2 ◽

Rapid virological response tailors the duration of treatment in hepatitis C virus genotype 3 patients treated with pegylated interferon alfa-2a and ribavirin in Pakistan

International Journal of Infectious Diseases ◽

10.1016/j.ijid.2013.05.012 ◽

2013 ◽

Vol 17 (11) ◽

pp. e1017-e1021 ◽

Cited By ~ 5

Author(s):

Uzma Gill ◽

Hafsa Aziz ◽

Muzaffar Lateef Gill

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Virological Response ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Genotype 3 ◽

Duration Of Treatment ◽

Virus Genotype ◽

Short versus standard treatment with pegylated interferon alfa-2a plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the CLEO trial

http://isrctn.org/> ◽

10.1186/isrctn29259563 ◽

2013 ◽

Author(s):

Adriano M Pellicelli

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Standard Treatment ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Virus Genotype ◽

Genotype 2 ◽

Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial

Hepatology International ◽

10.1007/s12072-014-9555-3 ◽

2014 ◽

Vol 8 (4) ◽

pp. 517-526 ◽

Cited By ~ 5

Author(s):

Mitchell L. Shiffman ◽

Hugo Cheinquer ◽

Christoph P. Berg ◽

Thomas Berg ◽

Cláudio de Figueiredo-Mendes ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Virological Response ◽

Final Analysis ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Genotype 2 ◽

Analysis of variables and interactions among variables associated with a sustained virological response to pegylated interferon alfa-2a plus ribavirin in hepatitis C virus genotype 3-infected patients

International Journal of Infectious Diseases ◽

10.1016/j.ijid.2012.03.012 ◽

2012 ◽

Vol 16 (8) ◽

pp. e597-e602 ◽

Cited By ~ 14

Author(s):

Hafsa Aziz ◽

Abida Raza ◽

Yasir Waheed ◽

Uzma Gill ◽

Muzaffar Lateef Gill

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Sustained Virological Response ◽

Virological Response ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Genotype 3 ◽

Virus Genotype ◽

Predictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4

Annals of Saudi Medicine ◽

10.4103/0256-4947.51816 ◽

2009 ◽

Vol 29 (1) ◽

pp. 4-14 ◽

Cited By ~ 25

Author(s):

Hamad Al Ashgar ◽

Ahmed Helmy ◽

Mohamed Q. Khan ◽

Khalid Al Kahtani ◽

Mohammed Al Quaiz ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Sustained Virological Response ◽

Virological Response ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Virus Genotype ◽

Genotype 4 ◽

Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial

BMC Gastroenterology ◽

10.1186/1471-230x-10-21 ◽

2010 ◽

Vol 10 (1) ◽

Cited By ~ 17

Author(s):

Fabrizio Mecenate ◽

◽

Adriano M Pellicelli ◽

Giuseppe Barbaro ◽

Mario Romano ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Standard Treatment ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Virus Genotype ◽

Genotype 2 ◽

Faculty of 1000 evaluation for Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718020710.793480337 ◽

2013 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Phase 2 ◽

Genotype 1 ◽

Virus Genotype ◽

Double Blind ◽

Phase 2 Trial ◽

Eight-week regimen of antiviral combination therapy with peginterferon and ribavirin for patients with chronic hepatitis C with hepatitis C virus genotype 2 and a rapid virological response

Liver International ◽

10.1111/j.1478-3231.2008.01736.x ◽

2009 ◽

Vol 29 (1) ◽

pp. 120-125 ◽

Cited By ~ 8

Author(s):

Hidenori Toyoda ◽

Takashi Kumada ◽

Seiki Kiriyama ◽

Yasuhiro Sone ◽

Makoto Tanikawa ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Virological Response ◽

Virus Genotype ◽

Genotype 2 ◽

Peginterferon And Ribavirin

24 Weeks Treatment with Pegylated Interferon Alfa Plus Ribavirin May Be Possible in Genotype 1 Chronic Hepatitis C Patients with Rapid Virological Response Who Have Low Pretreatment Viremia

Korean Journal of Gastroenterology ◽

10.4166/kjg.2010.56.1.33 ◽

2010 ◽

Vol 56 (1) ◽

pp. 33 ◽

Cited By ~ 3

Author(s):

Sung Soo Moon ◽

Hyoun Gu Kang ◽

Jeong Ah Seo ◽

Eun Uk Jung ◽

Sang Heon Lee ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Virological Response ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Genotype 1 ◽

Pegylated Interferon Alfa ◽

Chronic Hepatitis C Patients

Possible determinants of rapid virological response suggesting shorter courses of combination therapy for hepatitis C virus genotype 2

Hepatology ◽

10.1002/hep.22173 ◽

2008 ◽

Vol 48 (1) ◽

pp. 342-342 ◽

Cited By ~ 1

Author(s):

Chia‐Yen Dai ◽

Wan‐Long Chuang ◽

Jee‐Fu Huang ◽

Ming‐Yen Hsieh ◽

Ming‐Lung Yu

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Combination Therapy ◽

Virological Response ◽

Virus Genotype ◽

Genotype 2